Indeed, it has been recently suggested that in human subjects excess LCACs can be converted to metabolites as diacylglycerol and ceramides and activate stress kinases, thus disturbing insulin signaling and contributing to insulin resistance [58, 59]. The gene discussed is INS; the disease is Insulin resistance.